Programmed Cell Death Protein 1/Programmed Cell Death Ligand-1 Axis activates Intracellular ERK Signaling in Tumor Cells to Mediate Poor Prognosis in T-cell Lymphoma
Cited by 1
Related Papers
Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma
|Cancer Biology and Medicine|2019|28
Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T‐cell lymphomas
|Hematological Oncology|2019|27